ARDT as reported
Ardent Health, Inc. reported $6.41B of revenue over the trailing twelve months, +3.3% on the year before. 9 reported series are charted on this page, each one as filed.
$6.41B
Revenue, trailing twelve months · to Q2 2026 · +3.3% against the twelve months before
- Net Income
- $78M
Net Income · −69% year on year · trailing twelve months to Q2 2026
- Op Margin
- 3.2%
Op Margin · trailing twelve months to Q2 2026
- EPS
- $0.55
EPS · −70% year on year · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $6.41B | +3.3% | Q2 2026 |
| Net Income | $78M | −69% | Q2 2026 |
| EPS | $0.55 | −70% | Q2 2026 |
| Op Margin | 3.2% | n/a | Q2 2026 |
| Net Margin | 1.2% | n/a | Q2 2026 |
| ROE | 11% | n/a | Q2 2026 |
| ROA | 2.6% | n/a | Q2 2026 |
| ROIC | 13% | n/a | Q2 2026 |
| P/E | 20.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Ardent Health, Inc. (ARDT) - Revenue & ProfitRevenue & ProfitArdent Health, Inc. (ARDT)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Care Facilities
Ranks #28 of 28 by Smart Score